This is an outdated version published on 2023-10-24. Read the most recent version.

Mitral Stenosis Berat pada Penyakit Jantung Rematik

Authors

  • Cokorda Istri Padmi Suwari Warmadewa University
  • Widyawati Desak Gede Cardiologist Bhayangkara Hospital Denpasar, Bali

DOI:

https://doi.org/10.25077/jka.v12i2.2245

Abstract

Rheumatic Heart Disease (RHD) has high morbidity and mortality. Cardiac valve disorders after rheumatic fever are the leading cause of heart failure in children and young adults. A comprehensive understanding of RHD can help early diagnosis and provide optimal management in the future. It has been reported that a 55-year-old man came to the heart clinic of Bhayangkara Hospital Denpasar for routine control of heart disease. The patient has been diagnosed with rheumatic heart disease since 2018. The patient complains of shortness of breath when walking long distances and doing strenuous activities. The patient was diagnosed with CHF FC II ec RHD + MS moderate-severe (Wilkins score 8) + AF NVR (CHA2DS2VASc 3) and treated with heart failure and antiplatelet medication. Mitral stenosis due to RHD produces the typical pathological features seen in Transthoracic echocardiography (TTE), including fibrous thickening and calcification of the valve leaflets, fusion of the commissures, and thickening and shortening of chordae tendineae. Chronic stress overload on the LA due to MS can cause LA dilatation and trigger AF. RHD patients with AF are recommended for anticoagulation for stroke prevention. Patients with acute rheumatic fever clinical features should be evaluated further and given long-term therapy to prevent more severe heart problems.

Keywords:  atrial fibrillation, mitral stenosis, rheumatic  heart  disease

Downloads

Additional Files

Published

2023-10-24

Versions

How to Cite

Suwari, C. I. P., & Gede, W. D. (2023). Mitral Stenosis Berat pada Penyakit Jantung Rematik. Jurnal Kesehatan Andalas, 12(2), 93–99. https://doi.org/10.25077/jka.v12i2.2245

Issue

Vol. 12 No. 2 (2023): Online July 2023

Section

Case Reports

License

Authors retain copyright and grant the Jurnal Kesehatan Andalas right of first publication with the work simultaneously licensed under a Creative Commons Attribution-ShareAlike (CC BY-SA 4.0) license that allows others to share (copy and redistribute the material in any medium or format) and adapt (remix, transform, and build upon the material) the work for any purpose, even commercially with an acknowledgement of the work's authorship and initial publication in Jurnal Kesehatan Andalas.

Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in Jurnal Kesehatan Andalas.

Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).